ArticleClinicoEconomics and outcomes research : CEOR2014

Clinical outcomes and health care costs combining metformin with sitagliptin or sulphonylureas or thiazolidinediones in uncontrolled type 2 diabetes patients.

Luca Degli Esposti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.